Article

PDF
Access to the PDF text
Advertising



Archives of cardiovascular diseases
Volume 104, n° 12
pages 604-610 (décembre 2011)
Doi : 10.1016/j.acvd.2011.05.010
Received : 3 December 2010 ;  accepted : 9 May 2011
One-year clinical outcomes in patients with chronic renal failure treated by percutaneous coronary intervention with drug-eluting stent
Résultats cliniques à un an de l’angioplastie coronaire avec stent actif chez les patients avec insuffisance rénale chronique
 

Figure 1




Figure 1 : 

Event rates according to renal function and stent type (unadjusted). BMS: bare metal stent; CV: cardiovascular; DES: drug-eluting stent; MACE: major adverse cardiac events; ST: stent thrombosis; TLR: target lesion revascularization.


Figure 2




Figure 2 : 

One-year event-free survival according to renal function and the type of stent (Kaplan-Meier). BMS: bare metal stent; CRF: chronic renal failure; DES: drug-eluting stent; MACE: major adverse cardiac events.

EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline